Skip to content
BoardCited

Federal agencies: FDA, DEA, HHS, CMS, CPSC, OSHA — authority, inspections, enforcement

3 free Uniform MPJE practice questions on this topic, with the answer, a reason for every option and the source. The full bank has 40 questions here.

Question 1Single answer

A community pharmacy operates under state pharmacy law, regularly dispenses on prescriptions, and does not compound or manufacture outside the regular course of retail dispensing. Regarding FDA's expanded records-inspection authority for prescription drug manufacturers, this pharmacy:

  1. Ais subject to it only after an FDA warning letter
  2. Bis exempt from that expanded records authority
  3. Cis subject to it exactly as a manufacturer is
Show answer and sources

Answer: B. is exempt from that expanded records authority

Pharmacies that conform to local pharmacy law, regularly dispense on prescriptions, and do not manufacture or compound outside retail dispensing are exempt from FDA's expanded records-inspection provision (21 U.S.C. 374(a)(2)(A)).

  • A. Incorrect: the exemption is not lifted by a warning letter; it depends on the pharmacy's activities.
  • B. Correct: this statutory exemption covers ordinary dispensing pharmacies.
  • C. Incorrect: the statute exempts qualifying pharmacies from the manufacturer records provision.
  1. [1] 21 U.S.C. §374 — FDCA inspections . §374(a)(2)(A); §374(a)(1)
Question 2Single answer

An FDA investigator presents credentials and a written notice at a drug repackager, but the pharmacist in charge refuses to let the investigator enter. Under the FDCA, this refusal is:

  1. Aa prohibited act under the FDCA
  2. Blawful unless FDA first obtains a warrant
  3. Clawful if the firm offers a later date
Show answer and sources

Answer: A. a prohibited act under the FDCA

Refusing to permit an entry or inspection authorized by 21 U.S.C. 374 is a prohibited act (21 U.S.C. 331(f)).

  • A. Correct: refusing an authorized FDA inspection is a prohibited act.
  • B. Incorrect: the FDCA authorizes entry on credentials and written notice; refusing it is prohibited.
  • C. Incorrect: the statute contains no right to put off an authorized inspection.
  1. [1] 21 U.S.C. §331 — FDCA prohibited acts . §331(f)
Question 3Single answer

A pharmacy receives a drug shipped from an out-of-state manufacturer. While the drug is held for sale, a pharmacy employee relabels the stock bottles with a later, false expiration date. Under the FDCA, this act is:

  1. Aoutside the FDCA, because the drug has already completed its interstate shipment
  2. Boutside the FDCA, because only the board of pharmacy regulates stock labels
  3. Cprohibited, because it misbrands a drug held for sale after interstate shipment
Show answer and sources

Answer: C. prohibited, because it misbrands a drug held for sale after interstate shipment

Any act on a drug held for sale after interstate shipment that causes it to be adulterated or misbranded is a prohibited act (21 U.S.C. 331(k)).

  • A. Incorrect: the FDCA covers drugs held for sale after interstate shipment.
  • B. Incorrect: state regulation does not remove FDCA jurisdiction over misbranding.
  • C. Correct: section 331(k) reaches acts on drugs held for sale after interstate shipment.
  1. [1] 21 U.S.C. §331 — FDCA prohibited acts . §331(k)

Practise all 40 questions on this topic

Tutor mode, timed blocks and progress tracking.

Start free